Roy Doumani, Director at Kite Pharma, Inc. (KITE), sold 25,000 shares at $84.46 ($2.1M) on 2017-06-07, disclosed to the SEC on 2017-06-09.
Open-market sale of $2.1M KITE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $84.46 | 10,000 | $845K | 40.0% |
| 2 | $84.46 | 10,000 | $845K | 40.0% |
| 3 | $84.53 | 5,000 | $423K | 20.0% |
| Total | $84.47 avg | 25,000 | $2.1M | 100% |
| Filing → |